Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127659 · ClinicalTrials.gov registry record · Phase 4
Testosterone Replacement in Men With Diabetes and Obesity
A Phase 4 study, sponsored by University at Buffalo.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
NCT01127659 is a Phase 4 study that has completed, run by University at Buffalo. The registered enrollment target is 137 participants.
The verdict
NCT01127659, a Phase 4 study, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of having testosterone deficiency in men with diabetes and with obesity. The study will also evaluate the effect of testosterone therapy. This will be done by comparing the changes in several body response indicators following treatment with testosterone in diabetic or obese-non diabetic men with low testosterone levels and comparing them to diabetic or obese-non diabetic men with low testosterone who are not treated with testosterone.
Interventions
- DRUG placebo
- DRUG testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2010-05 |
| Est. Completion | 2015-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127659
The ClinicalTrials.gov registry entry for NCT01127659 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01127659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01127659 about?
NCT01127659 is a clinical study titled "Testosterone Replacement in Men With Diabetes and Obesity". The purpose of this study is to examine the effect of having testosterone deficiency in men with diabetes and with obesity. The study will also evaluate the effect of testosterone therapy. This will be done by comparing the changes in several body response indicators following treatment with testost...
What is the current status of trial NCT01127659?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2010-05. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01127659?
The interventions under investigation include: placebo (DRUG), testosterone (DRUG).
Who is sponsoring clinical trial NCT01127659?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.